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Abstract
Background: This study evaluated the effect of pomegranate seed oil (PSO) supplementation, rich in punicic acid
(55 %/C18:3-9c,11 t,13c/CLNA), on the lipid profile and on the biochemical and oxidative parameters in the gastrocnemius
muscle and adipose tissues of healthy rats. Linseed oil (LO), rich in linolenic acid (52 %/C18:3-9c12c15c/LNA) was
used for comparison.
Methods: Male Wistar rats (n = 56) were distributed in seven groups: control (water); LNA 1 %, 2 % and 4 %
(treated with LO); CLNA 1 %, 2 % and 4 % (treated with PSO), po for 40 days. The percentages were compared
to the daily feed intake. Fatty acid profile were performed by gas chromatography, antioxidant enzymes activity
by spectrophotometer and the adipocytes were isolated by collagenase tissue digestion. Analysis of variance
(ANOVA) was applied to check for differences between the groups (control, LNAs and CLNAs) and principal component
analysis (PCA) was used to project the groups in the factor-place (PC1 vs PC2) based on the biochemical responses
assessed in the study.
Results: The fatty acids profile of tissues showed that the LNA percentages were higher in the animals that were
fed LO. However, PA was only detected in the adipose tissues. Conjugated linoleic acid (CLA) was present in all
the tissues of the animals supplemented with PSO, in a dose dependent manner, and 9c11t-CLA was the
predominant isomer. Nevertheless there were no changes in the total weight gain of the animals, the weights
of the tissues, and the oxidative stress parameters in the muscle. In addition, there was an increase in the size
of the epididymal fat cells in the groups treated with PSO. Principal component analysis (PCA) showed that the
CLNAs groups were arranged separately with a cumulative variance of 68.47 %.
Conclusions: The results show that PSO can be used as a source of CLAs but that it does not cause changes in
body modulation and does not interfere in the antioxidant activity of healthy rats.
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Highlights
– Effects of pomegranate seed oil supplementation
were investigated.
– Lipid profile and biochemical parameters in rat’s
tissues are analyzed.
– Pomegranate seed oil supplementation did not
reduced adipose tissue.
– Punicic acid was incorporated in adipose tissue but
not in muscle.
– Punicic acid was metabolized to conjugated linoleic
acid.
Background
Since its discovery, the conjugated linoleic acids (CLAs)
have been extensively investigated with respect to its
beneficial effects to the body, with studies focused
mainly on their anti-adipogenic activity. However, the
results so far are inconclusive and controversial. An-
other type of conjugated, conjugated linolenic acid
(CLNAs), has also been drawing attention recently and
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has been the subject of research to evaluate its effects
on the body. Because they are metabolized to CLAs
form in several animal models, studies are suggesting
that they have the same effects of CLAs. In this line,
the objective of this study was to evaluate the supple-
mentation effect with pomegranate seed oil (PSO), rich
in Punicic acid (CLNA) on the lipid profile and on the
biochemical and oxidative parameters in the muscle
and adipose tissues of healthy rats
Introduction
Conjugated fatty acids (CFAs) is the general term for a
group of positional and geometric isomers of polyun-
saturated fatty acids with conjugated double bonds [1].
Interest in the health benefits of CFAs is increasing be-
cause they have been shown to possess pharmacological
activities which are relevant to the prevention and
treatment of atherosclerosis, obesity, cancer and hyper-
tension [2, 3].
There are CFAs of linoleic acid and α-linolenic acid.
Conjugated linoleic acids (CLAs) comprise a group of
positional and geometrical isomers of octadecadienoic
acid (18:2 ω–6), in which the two double bonds are
conjugated. CLAs naturally occur in foods from rumi-
nants and in milk and dairy products in very small
amounts [4]. Conjugated α-linolenic acids (CLNAs)
have three double bonds conjugated together. Unlike
CLA, CLNA isomers are present at much higher levels
in certain seed oils [5].
There are many studies evaluating the beneficial ef-
fects of CLAs to the body, especially in some experimen-
tal animal models (mice, rats, hamsters, pigs). The main
focus of these studies is the ability of CLAs to reduce
adipose tissue in several animal models, as well as affect-
ing muscle mass [6, 7]. Another factor that has drawn
attention is that it has been shown that CLAs have in
vitro and in vivo antioxidant activity, and this could be a
possible explanation for their beneficial health effects [8,
9]. However, some results are controversial and even
show other adverse effects. In addition, the effects in
humans are still questionable, and the biochemical
mechanisms through which CLAs mediate their po-
tential effects could produce undesirable metabolic al-
terations [3, 10]. Furthermore, differences have been
observed in the effects/benefits of CLAs, both in asso-
ciation and between their individual isomers, which
may partly explain some of the inconsistent results ob-
tained experimentally [7, 10, 11].
Although the information on the effects of CLNAs is
even more limited compared to CLAs, and does not pro-
vide a consensus in the literature regarding their effects
on animal and human organisms, some studies have
demonstrated that CLNAs have a cytotoxic effect on
cultured human tumor cells [12–14], that they inhibit
carcinogenesis [15–17], and that they alter lipid metab-
olism in animals [18–21]. It has been found that differ-
ent CLNA isomers exert different bioactivities [22] but
their mechanisms of action are unclear. Furthermore,
studies have shown that CLNAs could be metabolized
into CLA in vivo [23–25], suggesting that the health
benefits may be due to the CLA. These researchers sug-
gest that CLnAs may be metabolized to CLAs via a Δ13
saturation reaction catalyzed by a NADPH (nicotinamide
adenine dinucleotide phosphate) dependent enzyme,
which is either a novel enzyme capable of recognizing
conjugated trienoic acid or the enzyme active in the leu-
kotriene B4 reductive pathway. The incorporation and
metabolism of orally administered punicic acid (PA), one
isomer of CLNA, in rat tissues and plasma were studied
over a 24-h period by Yuan et al. [25]. The results show
that PA was incorporated and metabolized to 9c,11 t
CLA in rat plasma, liver, kidney, heart, brain, and adi-
pose tissue. Therefore natural resources containing
CLNA could be a potential dietary source of CLA, fol-
lowing PA metabolism.
PA (C18:3-9c,11t,13c), which is also known as tricho-
sanic acid, is an isomer of CLNAs that has aroused
great interest in recent years. It is found in high
amounts (> 50 %) in pomegranate seed oil (PSO) [26].
For this reason, PSO has been increasingly investigated
as a potent functional food and/or nutraceutical ingredi-
ent in foods [27]. According to Koba et al. [28], because
pomegranate abounds in PA its seed oil represents a suit-
able source for the investigation of the physiological roles
of this CLNA isomer.
Given the limited and often contradictory information
that exists about this issue, further studies regarding the
function of CLNAs in animal organisms, as well as their
single isomers, is required [26]. Furthermore, most stud-
ies assess the effects of CLNAs in specific physiological
conditions such as cancer and other diseases, the physio-
logical effects and mechanisms of action of punicic acid
in healthy body have not been well characterized. We
hypothesized that punicic acid present in the PSO it can
be incorporated in the form of CLA in the animal tissues
and present the effects in body composition modulation
(reducing body fat and increased lean mass), lipid profile
and antioxidant activity in this tissues, which are attrib-
uted to supplementation with CLAs isomers. Hence the
aim of this study was to evaluate the effect of supple-
mentation with pomegranate seed oil, rich in punicic
acid, on the lipid profile, and also its influence on the
biochemical and oxidative parameters in the muscle and
adipose tissue of healthy rats.
Results and discussion
Table 1 shows the results in relation to weight gain, feed
and calorie intake, feed efficiency coefficient (FEC) and
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tissue weight. Supplementation with PSO and LO sig-
nificantly reduced total food intake in the groups supple-
mented with a dose of 4 % but there was no significant
difference between the groups regarding the total weight
gain of the animals. This result can be explained by the
amount of calories consumed by the animals. Adding to-
gether the calories from the consumption of commercial
feed that was offered ad libitum (Kcal/gram of feed) to
the calories in the amount of oil that was offered, no dif-
ferences were observed between the groups. The results
of the gastrocnemius muscle weight, retroperitoneal adi-
pose tissue and the epididymal adipose tissue are pre-
sented as a percentage relative to the total body weight
of the animals. These results show that supplementation
with both LO and with PSO in all the concentrations
employed, did not statistically affect the weight of these
tissues.
Conjugated fatty acids are commonly reported as a
reductor of adipose tissue while increasing body lean
mass [3, 20, 25, 29] and therefore, several studies have
been conducted aiming to change the body weight of
the animals that consumed CLNAs. However, studies
have reported conflicting results regarding the role of
CLNAs in weight gain and body composition. Koba et al.
[30] evaluated how CLNAs affected body fat in rats and
they found that feeding CLNAs resulted in a reduction in
the adipose tissue weight. In contrast, supplementation
with 1 % CLNAs (PA and/or α-ESA = α-eleostearic acid
C18:3-9c,11 t,13 t) for six weeks did not significantly affect
food intake, body weight or the tissues in mice [25, 31].
Yamasaki et al. [19] reported that body weight and adipose
tissue were not affected in mice fed with experimental di-
ets containing 0.12 and 1.2 % of PSO that was rich in PA,
for three weeks. Arao et al. [32] showed that consumption
of a diet supplemented with 9 % safflower oil and 1 %
PSO for two weeks did not affect the weight of abdominal
white adipose tissue in Otsuka Long-Evans Tokushima
Fatty rats (OLETF- spontaneously hyperglycemic rats with
long-term diabetic complications). However, Koba et al.
[30] showed that CLNAs decreased the weight of perirenal
fat tissue to a greater extent, when compared to linoleic
acid (LA), α-linolenic acid (LNA) and conjugated linoleic
acid (CLA) in rats. The same group showed that supple-
mentation with PSO decreased the weight of perirenal
adipose tissue of mice in a dose-dependent manner after
four weeks of feeding [20]. In contrast, Nemer [33] re-
ported that mice fed with 2 % PA showed higher body
weight gain and improved feed efficiency coefficient when
compared to animals fed with 1 % PA and the control diet
for 16 weeks. In addition, the animals fed with 1 % and
2 % of PA had reduced muscle weight (quadriceps) com-
pared to the control group, but no difference was ob-
served regarding the weight of the epididymal adipose
tissue.
In the present study, the lipids obtained from the ani-
mal tissues supplemented with LO and PSO were ex-
tracted to analyze the fatty acid profile of the same.
Therefore, it was possible to estimate the total lipid
content of each tissue, as can be seen in Tables 2, 3 and
4, which show the percentage of fatty acids found in
the lipids of the muscle, and the retroperitoneal and
epididymal adipose tissues. Supplementation with PSO
did not alter the lipid content of the muscle (gastrocne-
mius) and adipose (retroperitoneal and epididymal) tis-
sues. The analysis of the composition of fatty acids in
these tissues showed that, in general, the percentages of
α-linolenic acid (LNA) were higher in the animals fed
linseed oil (LO) in a dose-dependent manner. However,
only traces of punicic acid (PA) were found in the
muscle tissue of animals supplemented with PSO/
CLNA. Nevertheless, it was possible to detect this fatty
acid in the adipose tissue in percentages ranging from
2.13 to 4.99 % (retroperitoneal) and 2.13 to 4.83 % (epi-
didymal). Interestingly, CLAs were present in all the
tissues, in a dose-dependent manner in relation to what
was provided. The 9c11t-CLA isomer was the predom-
inant form and it was found in an even higher percent-
age than PA in the fat tissue (3.18 % to 9.58 %). In
terms of the gastrocnemius muscle it was observed that
there was also an increase in the C22:4 ω-6 in the
Table 1 Body weight and feed intake of rats supplemented with different oils
Parameters Control LNA 1 % LNA 2 % LNA 4 % CLNA 1 % CLNA 2 % CLNA 4 %
Initial weight (g) 110 ± 10 107 ± 15 111 ± 10 113 ± 11 114 ± 5 112 ± 7 114 ± 10
Weight gain (g) 211 ± 13 212 ± 14 209 ± 23 205 ± 22 209 ± 17 210 ± 16 213 ± 23
Total feed intake (g) 1023 ± 40a 968 ± 46abc 971 ± 7abc 884 ± 2c 1035 ± 26a 1000 ± 73ab 926 ± 11bc
FEC 0.21 0.22 0.22 0.23 0.20 0.21 0.23
Calorie intake (Kcal) 2985 ± 115 2912 ± 134 3006 ± 20 2897 ± 6 3111 ± 76 3093 ± 214 3033 ± 34
Muscle (%w/w) 1.96 ± 0.44 1.75 ± 0.19 1.80 ± 0.11 1.84 ± 0.19 1.83 ± 0.29 1.73 ± 0.27 1.73 ± 0.26
Retroperitoneal (%w/w) 2.32 ± 0.57 2.55 ± 0.60 3.02 ± 1.02 2.77 ± 0.41 2.95 ± 0.89 2.41 ± 0.64 2.57 ± 0.74
Epididymal (%w/w) 2.76 ± 0.69 3.15 ± 0.61 3.14 ± 0.78 3.11 ± 0.57 3.39 ± 0.78 2.82 ± 0.65 3.29 ± 0.71
Results expressed as mean ± standard deviation. Different letters in the same row are statistically different from each other (p < 0.05)
(%w/w) percentage of tissue weight compared to total body weight, FEC feed efficiency coefficient
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groups receiving LO. However, this fatty acid was re-
duced in all the groups supplemented with LO and
PSO when compared with the control group in the fatty
tissues. In the epididymal adipose tissue it was also pos-
sible to observe a reduction in fatty acids C18:1ω-9,
C18:2ω-6 and C22:6ω-3 in the CLNA-supplemented
groups.
The results presented here agree with some other
studies that have shown that CLNAs are metabolized to
CLAs, and also that the isomer C18:2-9c11t was de-
tected in the tissues (liver, kidney, heart, adipose tissue,
mammary gland and intestine) of groups supplemented
with PA [23, 33–35]. Consequently, many of the func-
tions of these isomers are due to CLAs. The aforemen-
tioned authors also assessed the possibility that CLNAs
can be converted to CLA by a Δ13 saturation reaction
performed by a NADPH-dependent enzyme which is an
enzyme that recognizes conjugated trienoic acid, or is a
active enzyme in the reductive pathway of leukotriene
B4. Yuan et al. [25] showed that PA was rapidly con-
verted to 9c,11t-CLA in the plasma and various tissues
of rats. They observed that neither PA nor CLA were
detected immediately after treatment (time zero), but
both were detected in the tissues and plasma of rats 4, 8,
12 and 24 h after treatment (each rat was fed with about
645 mg of PA). The amounts of CLA and PA in the liver
and plasma of the animals were larger than in the heart,
kidney and adipose tissue. In our study, Tables 3 and 4
show the presence of PA in adipose tissue; CLA was
present in all three tissues and the epididymal adipose
tissue presented the highest percentage. These findings
suggest that the incorporation of the isomers of CLAs
and CLNAs is dependent/specific on tissue. According
to Reena et al. [36] the composition and organization of
lipids in biological membranes are important factors that
determine their fluidity. In this regard, further studies
are required to assess the mechanisms of action of these
specific fatty acids in animal tissues.
Although the PA present in the PSO was metabolized
and incorporated into tissues in the form of CLAs, no
changes were observed in the morphology of the muscle
tissue (gastrocnemius) of the animals. However, it can be
seen that there was a significant increase in cell diameter
of the groups supplemented with 4 % and LO in all the
groups supplemented with PSO when compared with
the control group (Table 5). Furthermore, there was a
decrease in cellularity in these groups, indicating that
supplementation with PSO did not increase the amount
of adipose cells, but the size of the adipocytes. The cellu-
larity was calculated from the total weight of the epi-
didymal adipose tissue mass, divided by the mass of the
adipocytes, which was obtained from the diameter.
The ability of conjugated linoleic acid (CLA) to change
body composition, increase lean body mass, and reduce
body fat in different species, such as mice, hamsters,
rats, pigs and humans, has been widely studied [7, 37,
38]. In the present study, because the PSO supplementa-
tion led to the incorporation of CLAs in the muscle and
adipose tissues, it was expected that there would be
changes in the area and diameter of the muscular tissue
and in the fat cell size. However, the results for these
parameters showed no significant differences. Further-
more, CLNA supplementation resulted in an increase
in the diameter of the epididymal adipocytes, although
this did not interfere in the cellularity. This result leads
us to believe that the effects were not attributed to the
9c11t-CLA isomer, which is the main form found in
animal tissue supplemented with PSO. Studies have
shown that each isomer of CLA has a distinct mode of
action [39–41]. According to Rahman et al. [37], the
supplementation of female mice with 0.5 % isolated iso-
mers of CLAs (9c11t or 10t12c), and with 0.5 % of a
Table 2 Fatty acids (FAs) profile in gastrocnemius muscle tissue of rats supplemented with different oils
FAs (%) Control LNA 1 % LNA 2 % LNA 4 % CLNA 1 % CLNA 2 % CLNA 4 %
C16:0 21.0 ± 0.6 20.1 ± 0.7 20.3 ± 0.8 20.6 ± 1.0 23.3 ± 2.2 23.1 ± 2.0 23.0 ± 2.8
C18:0 14.6 ± 2.4 15.0 ± 0.8 15.1 ± 1.8 17.5 ± 1.7 15.7 ± 1.8 16.0 ± 2.2 16.9 ± 2.6
C18:1c ω-9 11.2 ± 4.6 10.3 ± 0.2 9.7 ± 1.7 8.8 ± 1.5 12.1 ± 5.5 11.1 ± 5.3 10.0 ± 3.1
C18:2c ω-6 26.7 ± 1.4 27.6 ± 1.3 26.8 ± 1.5 25.0 ± 0.9 26.3 ± 3.6 26.1 ± 1.7 25.9 ± 2.4
C18:3c ω-3 1.0 ± 0.3a 2.4 ± 0.2b 3.7 ± 0.7bc 4.4 ± 1.2 0.9 ± 0.4a 1.0 ± 0.3a 0.9 ± 0.2a
CLA 9c11t 1.3 ± 0.4a 2.3 ± 0.6ab 3.4 ± 1.1b
CLA 10c12c 0.7 ± 0.4a 1.1 ± 0.3ab 1.6 ± 0.4b
C20:4 ω-6 15.2 ± 2.2 11.5 ± 0.3 10.9 ± 1.1 9.7 ± 1.1 10.0 ± 6.8 11.6 ± 3.1 11.2 ± 2.1
C22:4 ω-6 2.2 ± 0.2a 3.7 ± 0.2b 4.4 ± 0.3bc 5.4 ± 0.4 2.5 ± 0.4a 2.0 ± 0.4a 1.9 ± 0.2a
C22:6 ω-3 8.1 ± 1.6ab 9.3 ± 0.4a 9.0 ± 0.5a 8.5 ± 0.5ac 7.1 ± 1.8ac 5.7 ± 2.3bc 5.2 ± 0.6b
TL (%) 1.4 ± 0.1 1.5 ± 0.1 1.6 ± 0.3 1.4 ± 0.2 1.5 ± 0.3 1.3 ± 0.3 1.3 ± 0.3
Results expressed as mean± standard deviation (n= 4) of the fatty acid percentages; different letters in the same row are statistically different from each other (p< 0.05)
CLA conjugated fatty acid (C18:2), TL total lipids
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mixture of these isomers for six months, showed an in-
crease in muscle mass that was significantly greater in
the groups that received 10t12c-CLA and CLA-mix
group when compared to the group supplemented with
0.5 % of 9c11t and with the control diet (corn oil). In a
study using human adipocyte cells Obsen et al. [41]
concluded that only the 10t12c isomer-CLA decreased
the synthesis of new lipids, suggesting a mechanism for
anti-obesity for this isomer. Other studies have also re-
ported that the main isomer responsible for changing
effects on lipid metabolism and body composition is
10t12c-CLA [11, 38, 39, 42]. Although there is still no
consensus in the literature regarding the effects of
CLAs in the modulation of body composition, this re-
sult appears to be due mainly to the isomer 10t12c-
CLA. This would be a possible explanation for the re-
sults found here, since the PA present in the PSO was
metabolized in the studied tissues mainly as 9c11t-
CLA. Then our findings according to those found by
Lopes et al. [43] who investigated the effect of CLAs in
the number and size of adipocytes in inguinal and
retroperitoneal adipose tissue in Wistar rats. The diet
was modified by adding 5.1 % of palm oil and the ex-
perimental groups were supplemented for eight weeks
with isomers of CLAs as follows: 0.6 % of 9c11t; 0.6 %
of 10t12c; and 1.3 % of a mixture of 9c11t and 10t12c.
Supplementation with the 9c11t-CLA isomer increased
the size of the adipocytes, with a consequent reduction
in the number of adipocytes per unit area. According to
Queiroz et al. [44], very large adipocytes, which are
Table 3 Fatty acids (FAs) profile in retroperitoneal adipose tissue of rats supplemented with different oils
FAs (%) Control LNA 1 % LNA 2 % LNA 4 % CLNA 1 % CLNA 2 % CLNA 4 %
C13:0 3.00 ± 0.62 2.74 ± 0.44 2.95 ± 0.43 2.79 ± 0.71 2.67 ± 0.35 2.75 ± 0.47 2.62 ± 0.40
C14:0 1.14 ± 0.04 0.93 ± 0.06 0.98 ± 0.11 0.95 ± 0.04 1.08 ± 0.09 1.01 ± 0.08 0.94 ± 0.09
C15:0 0.22 ± 0.01 0.24 ± 0.04 0.28 ± 0.06 0.29 ± 0.02 0.24 ± 0.03 0.23 ± 0.04 0.21 ± 0.03
C16:0 21.85 ± 0.37 18.82 ± 0.87 19.33 ± 1.05 17.81 ± 0.50 20.33 ± 1.07 19.63 ± 2.15 18.15 ± 1.51
NI 0.20 ± 0.04 0.23 ± 0.03 0.19 ± 0.02 0.21 ± 0.02 0.18 ± 0.04 0.18 ± 0.01 0.16 ± 0.02
C16:1c 3.61 ± 0.26 2.79 ± 0.27 3.18 ± 0.48 2.91 ± 0.34 3.12 ± 0.45 3.08 ± 0.75 2.68 ± 0.61
C17:0 0.22 ± 0.01 0.23 ± 0.03 0.19 ± 0.03 0.20 ± 0.01 0.22 ± 0.02 0.22 ± 0.04 0.22 ± 0.02
C17:1 0.13 ± 0.02 0.11 ± 0.02 0.10 ± 0.01 0.10 ± 0.01 0.14 ± 0.04 0.14 ± 0.07 0.13 ± 0.06
C18:0 2.97 ± 0.10 2.93 ± 0.14 2.97 ± 0.18 2.76 ± 0.08 2.96 ± 0.82 2.80 ± 0.63 2.50 ± 0.31
C18:1t 0.10 ± 0.02b 0.15 ± 0.06ab 0.21 ± 0.06a
C18:1c ω-9 26.32 ± 0.60 24.42 ± 0.71 24.54 ± 0.55 23.68 ± 0.41 24.70 ± 3.06 22.68 ± 2.54 20.59 ± 1.68
NI 0.19 ± 0.03b 0.23 ± 0.04b 0.34 ± 0.05a
C18:2t 0.26 ± 0.05c 0.44 ± 0.06b 0.62 ± 0.06a
C18:2c ω-6 35.89 ± 0.44ab 36.93 ± 2.70a 31.44 ± 1.59abc 30.46 ± 1.10bc 33.15 ± 3.93abc 30.59 ± 3.93bc 28.64 ± 2.49c
C18:3c ω-6 0.12 ± 0.01c 0.12 ± 0.01c 0.11 ± 0.01c 0.14 ± 0.01bc 0.14 ± 0.02bc 0.16 ± 0.03ab 0.18 ± 0.01a
C18:3c ω-3 2.56 ± 0.09d 7.71 ± 0.74c 11.91 ± 0.78b 16.13 ± 1.32a 2.28 ± 0.25d 1.90 ± 0.17d 1.54 ± 0.09d
CLA 9c11t 3.18 ± 0.60c 6.07 ± 0.89b 9.58 ± 0.80a
CLA 10t12c 0.03 ± 0.00c 0.07 ± 0.00b 0.11 ± 0.01a
CLA 10c12c 1.51 ± 0.22c 2.91 ± 0.37b 4.43 ± 0.49a
C20:2 ω-6 0.29 ± 0.01a 0.22 ± 0.03b 0.19 ± 0.02bc 0.16 ± 0.01c 0.20 ± 0.03bc 0.21 ± 0.03bc 0.17 ± 0.01bc
C20:3 ω-6 0.13 ± 0.02 0.12 ± 0.02 0.12 ± 0.03 0.09 ± 0.01 0.11 ± 0.01 0.10 ± 0.02 0.10 ± 0.02
C20:4 ω-6 0.84 ± 0.08a 0.58 ± 0.06bc 0.50 ± 0.07bc 0.42 ± 0.03bc 0.61 ± 0.13b 0.57 ± 0.16bc 0.39 ± 0.05c
C22:2 0.10 ± 0.01b 0.15 ± 0.03a 0.15 ± 0.01a
C 24:0 0.08 ± 0.01c 0.23 ± 0.02b 0.27 ± 0.07ab 0.34 ± 0.04a
PA 2.13 ± 0.16c 3.37 ± 0.43b 4.99 ± 0.74a
α-ESA 0.19 ± 0.03b 0.25 ± 0.03ab 0.28 ± 0.05a
NI 0.17 ± 0.02b 0.34 ± 0.03a 0.41 ± 0.13a 0.34 ± 0.02a
C22:6 ω-3 0.26 ± 0.03ab 0.33 ± 0.05a 0.33 ± 0.10a 0.24 ± 0.02ab 0.16 ± 0.04bc 0.12 ± 0.04c 0.06 ± 0.00c
TL (%) 74 ± 17 76 ± 10 75 ± 7 75 ± 11 71 ± 7 69 ± 15 67 ± 9
Results expressed as mean ± standard deviation (n = 4) of the fatty acid percentages; different letters in the same row are statistically different from each other
(p <0.05)
NI not identified, CLA conjugated fatty acid (C18:2), PA punicic acid, α-ESA α-eleostearic acid, TL total lipids
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beyond the exhaustion of the storage capacity of fat, be-
come more lipolytic. This can trigger an increase in the
concentration of free fatty acids in plasma and also
damage non-adipose organ function, which is a process
identified as lipotoxicity.
The TBARS values in the muscle tissue (gastrocne-
mius) of the animals supplemented with oils rich in
LNA and CLNA/PA did not differ between the groups.
There were also no differences between the studied
groups with respect to the activity of antioxidant en-
zymes GPx and CAT, while the activity of SOD signifi-
cantly decreased in the groups LNA 4 % and all the
CLNA groups (1 %, 2 % and 4 %) in comparison to the
control group (Table 5). Studies have shown that CLNAs
suppress tumor cell growth by a mechanism that involves
lipid peroxidation [16, 45, 46]. Some researchers have
also reported that conjugated fatty acids have antioxi-
dant activity and that this could be a possible explan-
ation for their beneficial health effects [27, 47, 48].
According to Yang et al. [34], although the mechanisms
of biological activities related to CLNAs are linked to
oxidation, controversial results have been reported. It
has been argued that the presence of PUFAs in lipids
increases susceptibility to lipid oxidation, therefore re-
quiring an increase in the activity of antioxidant en-
zymes [superoxide dismutase (SOD), catalase (CAT)
and glutathione peroxidase (GPx)] to reverse this situ-
ation [36]. These authors showed that rats supple-
mented with oil rich in unconjugated PUFAs had
increased activity of antioxidant enzymes (SOD, CAT
Table 4 Fatty acids (FAs) profile in epididymal adipose tissue of rats supplemented with different oils
FAs (%) Control LNA 1 % LNA 2 % LNA 4 % CLNA 1 % CLNA 2 % CLNA 4 %
C13:0 2.72 ± 0.31 3.12 ± 0.44 2.76 ± 0.28 2.72 ± 0.40 3.38 ± 0.39 2.80 ± 0.26 3.24 ± 0.39
C14:0 1.08 ± 0.04 0.92 ± 0.05 0.93 ± 0.10 0.85 ± 0.07 1.00 ± 0.07 0.99 ± 0.06 0.95 ± 0.11
C15:0 0.27 ± 0.02a 0.27 ± 0.03a 0.21 ± 0.02b 0.20 ± 0.00b 0.25 ± 0.04ab 0.23 ± 0.02ab 0.23 ± 0.03ab
C16:0 20.57 ± 0.13 18.87 ± 0.47 17.85 ± 0.92 16.01 ± 0.27 19.36 ± 1.85 19.12 ± 2.50 18.01 ± 2.17
NI 0.27 ± 0.02a 0.26 ± 0.02a 0.25 ± 0.05a 0.21 ± 0.02ab 0.15 ± 0.06b 0.13 ± 0.05b 0.15 ± 0.02b
C16:1c 3.63 ± 0.23 3.17 ± 0.23 3.34 ± 0.45 3.36 ± 0.53 3.74 ± 0.73 3.60 ± 0.85 3.44 ± 0.76
C17:0 0.24 ± 0.01 0.25 ± 0.02 0.22 ± 0.01 0.20 ± 0.01 0.23 ± 0.03 0.22 ± 0.02 0.21 ± 0.02
C18:0 2.87 ± 0.12 2.84 ± 0.07 2.78 ± 0.13 2.57 ± 0.09 2.61 ± 0.42 2.59 ± 0.39 2.38 ± 0.32
C18:1t 0.34 ± 0.51 0.14 ± 0.02 0.17 ± 0.04
C18:1c ω-9 26.02 ± 0.30a 24.74 ± 0.35ab 24.24 ± 0.54ab 23.26 ± 0.33ab 23.86 ± 1.85ab 22.82 ± 1.98bc 20.28 ± 1.78c
NI 0.19 ± 0.03a 0.27 ± 0.04ab 0.33 ± 0.05b
C18:2t 0.31 ± 0.05a 0.44 ± 0.04 0.72 ± 0.11b
C18:2c ω-6 37.05 ± 0.27a 35.17 ± 0.56ab 32.83 ± 1.38ab 31.09 ± 0.63bc 32.99 ± 3.60a 31.13 ± 4.21bc 27.89 ± 2.41c
C18:3c ω-6 0.13 ± 0.02ab 0.13 ± 0.01ab 0.09 ± 0.04ad 0.05 ± 0.01cd 0.17 ± 0.03b 0.19 ± 0.04b 0.17 ± 0.04b
C18:3c ω-3 2.75 ± 0.09a 8.02 ± 0.25b 12.11 ± 0.29c 17.17 ± 1.57d 2.54 ± 0.25a 2.13 ± 0.30a 1.89 ± 0.24a
CLA 9c11t 3.38 ± 0.66a 5.71 ± 0.78b 9.40 ± 1.10c
CLA 10t12c 0.04 ± 0.01a 0.07 ± 0.01b 0.11 ± 0.02c
CLA 10c12c 1.52 ± 0.21a 2.56 ± 0.30b 4.11 ± 0.52c
C20:2 ω-6 0.24 ± 0.02 0.25 ± 0.02 0.22 ± 0.02 0.18 ± 0.02 0.24 ± 0.04 0.23 ± 0.04 0.20 ± 0.01
C20:3 ω-6 0.14 ± 0.02a 0.13 ± 0.02ab 0.13 ± 0.02ab 0.12 ± 0.01ab 0.14 ± 0.01a 0.11 ± 0.02ab 0.10 ± 0.01b
C20:4 ω-6 1.14 ± 0.21a 0.71 ± 0.16ab 0.71 ± 0.08ab 0.61 ± 0.13b 0.84 ± 0.28ab 0.75 ± 0.25ab 0.49 ± 0.12b
C22:2 0.11 ± 0.03a 0.14 ± 0.02ab 0.16 ± 0.01
C24:0 0.10 ± 0.02a 0.26 ± 0.03b 0.34 ± 0.09b 0.48 ± 0.09c
PA 2.13 ± 0.25a 3.04 ± 0.24a 4.83 ± 0.87b
α-ESA 0.18 ± 0.04a 0.23 ± 0.03ab 0.30 ± 0.09b
C22:4 ω-6 0.19 ± 0.03a 0.11 ± 0.02b 0.08 ± 0.01bc 0.05 ± 0.01c 0.12 ± 0.03b 0.09 ± 0.03bc 0.05 ± 0.02c
NI 0.15 ± 0.03a 0.37 ± 0.06b 0.49 ± 0.10b 0.49 ± 0.09b 0.13 ± 0.03a 0.10 ± 0.03a 0.06 ± 0.03a
C22:6 ω-3 0.29 ± 0.08ac 0.42 ± 0.10ab 0.48 ± 0.06b 0.37 ± 0.09ab 0.21 ± 0.06c 0.18 ± 0.07c 0.11 ± 0.03d
TL (%) 78 ± 6abc 83 ± 11ab 71 ± 6bc 67 ± 10c 91 ± 9a 71 ± 12bc 87 ± 10a
Results expressed as mean ± standard deviation (n = 4) of the fatty acid percentages; different letters in the same row are statistically different from each other,
p <0.05
NI not identified, PA punicic acid, α-ESA α-eleostearic acid, TL total lipids
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and GPx) in liver tissue when compared with the con-
trol, which received oil that was rich in saturated fatty
acids. According to the results of the present study, no
significant differences were observed in the lipid perox-
idation of the muscle tissue of the animals supple-
mented with oils rich in PUFAs, or the activity of CAT
and GPx enzymes that tissue.
However, the level of SOD was reduced in the gastro-
cnemius muscle of the groups receiving PSO when
compared to the control, but there is no dose–response
relationship with CLA content. It's possible that 1 %
level of PSO showed maximum reducing effect in muscle
SOD activity comparated to control group. Further there
was no significant difference between groups treated nor a
dose–response relationship in the SOD activity of the
LNA groups. Other authors also found no dose–response
effect of CLNAs on their works [49]. According to
Reena et al. [36], a reduction in the activity of antioxi-
dant enzymes may predispose cells to damage by free
radicals. Saha et al. [49] report that the decreased SOD
activity in organs suggests that the accumulation of
superoxide anion radical might be responsible for in-
creased lipid peroxidation. Santos-Zago et al. [50] stud-
ied the effects of supplementation of mice with CLAs
mix (2 % in relation to the feed intake) for 42 days and
observed a significant reduction in catalase activity in
serum. They concluded that the reduction of catalase
activity may indicate a reduced production of peroxide
which, in turn, indicates a lower degree of oxidative
stress. This work PSO did not affect muscle lipid perox-
idation, but reducing the levels of SOD. Thus, in model
of health rats, SOD could protect the tissue lipid mem-
brane of lipid peroxidation; it is a possible explanation
for the reduced levels of SOD these groups. Yuan et al.
[5] reported that oxidative stress is associated with various
clinical conditions and chronic diseases, and that CLNA
isomers could play a role in ameliorating oxidative stress.
However, given the small number of studies in the lit-
erature associated with the antioxidant activity in ani-
mal organisms and the results we obtained, (which
indicated a reduction in SOD enzyme activity in the
gastrocnemius muscle of animals given CLNA in three
concentrations) further studies are needed to identify
the action of PSO as an antioxidant in animal organ-
isms. Saha and Gosh [49] analyzed the influence of two
isomers of CLNA (0.5 % and 1 % of total lipids offered
for 21 days) in antioxidant activity against oxidative
stress induced by arsenic. The results showed that so-
dium arsenite altered the activity of antioxidant en-
zymes in plasma and tissue homogenates, while the
pressure increased the activity of SOD, CAT and GPx
to normal levels, but the results showed no dose–re-
sponse effect.
It not only the amount of total calories but also the fat
content or fatty acids profile dietary can make them
more susceptible to free radicals interact with membrane
lipids leading to the production of lipid hydroperoxides.
Thus, the intra-cellular antioxidant system (SOD, CAT
and GPx) play an important role under physiological
conditions. Our results show that there was no change
in total caloric intake, but existed a reduction in food in-
take in order to compensate the calories ingested by
supplementation with the oils. Moreover there were no
changes in muscle and adipose tissues weights, only on
their composition in LNA and CFAs accumulation be-
tween treated groups. Therefore the higher LNA accu-
mulation and the CLA-9c11t presence can explain the
alterations in SOD activity and adipocytes size.
In order to verify the associations between the charac-
teristics studied in the muscle and adipose tissues of the
rats included in the control group, LNAs and CLNAs,
principal component analysis (PCA) was applied to the
data, which had been previously auto-scaled (Fig. 1). Ac-
cording to the figure, it can be seen that the groups were
Table 5 Cell diameter and muscle oxidative stress parameters of rats supplemented with different oils
Parameters Control LNA 1 % LNA 2 % LNA 4 % CLNA 1 % CLNA 2 % CLNA 4 %
Epididymal cells
Diameter (μm) 70 ± 8.0c 76 ± 1.6bc 78 ± 9.0bc 84 ± 4.6ab 83 ± 3.3ab 88 ± 5.9a 90 ± 1.6a
Cellularity 7.1 × 10-9 ab 7.6 × 10-9 a 6.1 × 10-9 abc 5.3 × 10-9 c 5.3 × 10-9 c 4.9 × 10-9 c 5.7 × 10-9 bc
Muscle fibers
Average area (μm2) 1841 ± 149 2028 ± 311 2070 ± 155 1668 ± 70 1625 ± 64 1826 ± 312 1828 ± 145
Diameter (μm) 60 ± 2.4 66 ± 6.6 65 ± 5.2 57 ± 1.5 58 ± 2.4 60 ± 4.9 63 ± 3.2
Muscle tissue
TBARS (nmol MDA/mg) 3.2 ± 1.2 3.2 ± 0.8 2.2 ± 0.3 1.2 ± 0.6 3.0 ± 0.7 3.3 ± 0.8 2.6 ± 0.7
SOD (U/mg) 6.0 ± 0.6a 5.0 ± 0.6ab 5.5 ± 0.9ab 4.6 ± 0.6b 4.6 ± 0.6b 4.4 ± 0.6b 4.8 ± 0.8b
CAT (U/mg) 1.9 ± 0.5 1.7 ± 0.4 2.1 ± 0.5 1.5 ± 0.3 1.6 ± 0.3 1.8 ± 0.4 1.5 ± 0.4
GPx (U/mg) 0.07 ± 0.02 0.05 ± 0.01 0.06 ± 0.02 0.05 ± 0.02 0.06 ± 0.01 0.05 ± 0.01 0.06 ± 0.02
Results expressed as mean ± standard deviation. Different letters in the same row are statistically different from each other (p < 0.05)
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arranged separately, with a cumulative variance of
68.47 % (PC1 = 47.34 % and PC2 = 22.13 %, of the total
variation); mainly the groups that received pomegranate
seed oil (CLNA). PC1 was highly contributed by larger
weight gain, total lipids and diameter adipocyte in epi-
didymal adipose tissue, CLA and CLNA in the three tis-
sues, as lower weight and superoxide dismutase activity
in muscle, total lipids in muscle and retroperitoneal adi-
pose tissue, and LNA isomer in the three tissues. PC2
was mainly correlated to larger weight of adipose tissues
and diameter adipocyte, as lower weight gain and en-
zyme activities. The control group had negative scores
to the two PC while the CLNAs groups had positive
scores for both components. According to this analysis
it can be noted that CLNA was linked with greater
weight gain, larger adipocyte diameter and lower muscle
weight. These results show that in healthy rats, supple-
mentation with CLNA in the conditions set forth herein
did not show a beneficial effect in reducing adipose tis-
sue or increasing lean mass.
In rats under the conditions mentioned in our study,
some of the beneficial effects of PSO were not been
found. It seems that the main cause of this controversy
is the physiological conditions of animals, because most
of the rodents studies that showed significant effects of
PA on body composition or antioxidants system were
performed on high-fat diets, overweight and/or induced
stress conditions animals. This suggests that age,
species, tissue, type of supplementation and physio-
logical conditions could to influence in effects of conju-
gated fatty acids. So the controversial results in our
study may be due to the normal weight of our animals,
the duration of supplementation, the type of conjugated
isomers and supplementation without exercise training
or stress condition. Controversial results also were re-
lated in researches with humans when compared to an-
imals [51, 52]. Further researches are needed to clarify
this. Despite the fact that our study had some limita-
tions, it does not seem that these factors could have
influenced our findings significantly. The major limita-
tion was inability to measure the SOD gene expression.
Our results could be better explained by an analysis of
the SOD gene expression in muscle and an additional
study under of other possible changes in adipose tissue.
Conclusions
Supplementation with LO and PSO did not affect body
weight gain or muscle or fat tissues. LO was able to in-
crease the percentage of LNA in all tissues in a dose-
dependent manner, while punicic acid (CLNA) was
found in trace amounts and was metabolized and in-
corporated in the form of CLAs, mainly the isomer
C18:2-9c11t. The increase in the concentration of LNA
and/or CLNAs did not interfere significantly in lipid
peroxidation and antioxidant enzyme activity in muscle
tissue. Our findings show that PSO can be used as a
Fig. 1 Principal component analysis (PC1 × PC2) to show differences in the evaluated parameters. The groups evaluated were grouped in
different quadrants on the graph. Those who are on the positive side of the principal component 1 (x-axis) have the characteristics that are
shown in the first frame of the figure. Consequently, the groups that are on the negative side of the x-axis have the opposite characteristics.
This interpretation is also applied to the principal component 2 (y-axis), whose representative characteristics are show in the second frame
of the figure
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source of CLAs, but that it does not cause changes in
body modulation and does not interfere significantly in
the antioxidant activity of healthy animals.
Methods
Pomegranate seed oil (PSO), which was obtained by cold
pressing pomegranate seeds, was purchased from Green
Source Organics (Boynton Beach, USA). Samples of lin-
seed oil (LO), which were also obtained by cold pressing,
were provided by Vital Âtman (Uchôa, Brazil) and were
used for comparison. The major fatty acid of LO is a
non-conjugated analog of punicic acid. The principal fatty
acids found in the oils (determined by GC-MS) were: 6 %
C18:1-9c, 7 % C18:2-9c12c, 55 % C18:3-9c11t13c (punicic
acid); 16 % C18:3-9c11t13t and 7 % C18:3-9t11t13c for
PSO; and 22 % C18:1-9c, 15 % C18:2-9c12c, and 52 %
C18:3-9c12c15c (LNA) for LO.
This study was approved by the Ethics Committee on
Animal Experiments of the Faculty of Pharmaceutical Sci-
ences (Craft number: CEUA/FCF/72/2008/204), University
of São Paulo, Brazil. To evaluate the effect of PSO and
LO in vivo, 56 male Wistar rats, weighing between 50
and 70 g (four weeks old), were used in the experiment.
A balanced commercial diet (Nuvilab CR-1) and water
were offered ad libitum. The animals were kept in poly-
propylene cages (four rats/cage) in an environment
with controlled lighting (12 h light/dark cycle) at 25 °C
and 60 % humidity throughout the experimental period.
The animals were distributed in the following seven
groups of eight animals each, according to the initial
weight (so that the average weight between the groups
were similar): control, rats treated with water; LNA
1 %, rats treated with 1 % LO; LNA 2 %, rats treated with
2 % LO; LNA 4 %, rats treated with 4 % LO; CLNA 1 %,
rats treated with 1 % PSO; CLNA 2 %, rats treated with
2 % PSO; and CLNA 4 %: rats treated with 4 % PSO.
After a seven-day acclimatization period, the animals
started receiving the supplementation oils intragastri-
cally (po) using a gavage needle, whose percentages
were compared to the average daily feed intake. The an-
imals were weighed every week to calculate the weight
gain, and the feed efficiency coefficient (FEC) was ob-
tained according to the following relationship: animal
weight gain (g) ÷ feed intake (g). The experiment was
conducted for 40 days and on day 41, after fasting for
eight hours, the animals were anesthetized. The gastro-
cnemius muscle and the adipose tissues (retroperitoneal
and epididymal) were collected, weighed, and then frozen
in liquid nitrogen and stored at −80 °C until analysis.
Fatty acids profile of tissues
The lipids from the tissues were extracted using the
method described by Folch et al. [53]. The fatty acids
were transformed into methyl esters in accordance
with the method of alkaline esterification proposed by
Christie et al. [54], using NaOCH3 in methanol. The
extract was then injected into the gas chromatograph
[GC - Shimadzu 2010 with flame ionization detector
and fused silica (100 m and 0.25 mm internal diameter/
SP-2560) column] following the schedule described by
Baublits et al. [55]. The identification of fatty acids was
based on comparison with the retention times for the
mixture of methyl esters of the standards C4-C24 (Sigma
18919), PUFA-2 (Sigma 47015-U), CLAs (Sigma O5632/
16413) and punicic acid. The retention times were com-
pared and identified in accordance with what has been
presented in the literature. The results were expressed
as mean ± standard deviation of the percentages of fatty
acids present.
Morphometry of tissues
A small piece of muscle tissue from four animals from
each group was collected and immediately fixed in for-
malin (10 %). Sections (5 μm) were prepared and stained
with hematoxylin-eosin (HE) for the photomicroscopic
observations. The muscle fibers were analyzed by quan-
tification of the area and diameter of 100 fibers, which
were randomly obtained from the muscle tissue of each
animal. The image acquisition was performed at 400x
magnification (40x objective) using a Cool SNAP-Procf
(Media Cybernetics Inc., USA) camera coupled to a
microscope (Nikon Eclipse - E800, Japan). The mea-
surements were performed using the Image-Pro Plus
version 4.5 computerized imaging system (Media Cy-
bernetics Inc.). We calculated the area and the average
diameter per animal, and from these values the results
were expressed as mean ± standard deviation.
A small fragment of epididymal adipose tissue was also
collected from four animals in each group and the adi-
pocytes were isolated by collagenase tissue digestion
using the technique described by Rodbell [56] with some
modifications [57]. The fat coxin was chopped with scis-
sors into fine pieces and incubated in digestive buffer
(DMEM, 20 mM HEPES, 4 % BSA, collagenase II -
Sigma®- 1.0 mg/ml, pH = 7.45) for about 30 min at 37 °C
in a water bath with orbital shaking (150 rpm). The
sample was subsequently filtered through a plastic sieve
with fine mesh (which retains tissue debris and un-
digested vessels) and washed three times with 25 ml of
buffer (EHB buffer - Earle's salts, 20 mM HEPES, 1 %
BSA, sodium pyruvate 1 mM without glucose, pH =
7.45) maintained at 37 °C. For the morphometric ana-
lysis, cell suspension aliquots were evaluated under an
optical microscope (100x magnification) using a gradu-
ated ocular mobile diameter for cell measurement. In
each preparation, assuming that the isolated adipocytes
were spherical, the diameter of 100 cells was measured
with the aid of the Motic Images Plus images, version
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2.0 computerized system. This calculated the average
diameter (μM) per animal cell and from these values,
averages and final standard deviations, which were con-
sidered representative of each group.
Muscle homogenate and protein quantification
The muscle tissue was weighed and homogenized with a
potassium phosphate buffer 0.1 M (pH 7.0) at a propor-
tion of 1:4 (m/v). The homogenates were centrifuged at
15.000 rpm for 30 min at 4 °C and the supernatant was
used for the evaluation of lipid peroxidation and antioxi-
dant enzyme activity.
The protein content in the tissue homogenates was per-
formed in triplicate by the method of Bradford [58],
obtaining readings at a wavelength of 595 nm in a UV/Vis
spectrophotometer (Spectronic Genesystm® 20, Rochester,
USA). The amount of protein in the samples was cal-
culated from the standard curve using bovine serum
albumin (Sigma A4503).
Lipid peroxidation and antioxidant enzyme activity
The determination of lipid peroxidation in the muscle
homogenates was carried out by measuring the produc-
tion of thiobarbituric acid reactive substances (TBARS)
using the method described by Ohkawa et al. [59] with
minor adaptations. The TBARS concentrations were
calculated using a standard curve for 1,1´,3,3´-(TEP)
tetraethoxypropane (10–4 mol/L) and were expressed
as μmol of malondialdehyde (MDA) per milligram of
protein.
The cytoplasmic superoxide dismutase (SOD) activity
was evaluated according to the methods described by
[60], using a reaction medium containing cytochrome
C (100 mM), xanthine (500 mM), ethylenediaminetetra-
acetic acid (1 mM), potassium cyanide (200 mM) and
potassium phosphate buffer (0.05 M - pH 7.8). The re-
sults were expressed as units per milligram of protein.
One unit of SOD activity was defined as the amount of
enzyme required to inhibit the reaction rate by 50 % at
25 °C.
The catalase (CAT) activity was measured spectro-
photometrically by calculating the rate of degradation of
H2O2; the substrate of the enzyme was at 37 °C and
pH 8.0, according to the methods described by [61]. The
results were expressed as mMol of hydrogen peroxide
decomposed per minute per milligram of protein.
The glutathione peroxidase (GPx) activity was deter-
mined as described by [62] by measuring the decay of
the optical density at 340 nm, which was promoted by
the oxidation of NADPH during the reduction of oxi-
dized glutathione, which was catalyzed by glutathione
reductase. The results were expressed as units per milli-
gram of protein. The unit of enzyme activity was defined
as the amount of enzyme required to oxidize one mol of
NADPH per minute at 30 °C at pH 7.0.
Statistical analysis
The results were expressed as mean ± standard devi-
ation (n = 3). Initially, the homogeneity of variances was
checked by the Hartley/Levene test and then one-way
analysis of variance (ANOVA) was applied to check for
differences between the groups (control, LNAs and
CLNAs). Fisher’s LSD test was used to statistically de-
termine significant differences in the means. When the
data were not normal the Kruskal-Wallis test was used
in order to evaluate the statistical differences between
the groups. Probability values (p-value) below 0.05 were
considered to be statistically significant [63].
In order to detect associations between all the results
found in the rats included in the studied groups, princi-
pal component analysis (PCA) was used to project the
groups in the factor-place (PC1 vs PC2) based on the
biochemical responses assessed in the study. In this
study, PCA was used to better visualize the results ob-
tained experimentally because there were many variables
involved in the response of the groups. PCA aims to re-
duce the dimensionality of the original data set, preserv-
ing the greatest amount of information (variance) as
possible. For this purpose, the experimental results were
autoscaled using the z-score [(μ - X)/σ] and the PCA
analysis was based on linear correlations in which the
variances were calculated as sums of squares/n-1 [64].
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